HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

PURPOSE: We examined associations between tumor characteristics (human epidermal growth factor receptor 2 [HER2] protein expression, HER2 gene and chromosome 17 copy number, hormone receptor status) and disease-free survival (DFS) of patients in the N9831 adjuvant trastuzumab trial. PATIENTS AND MET...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Perez, Edith A., Reinholz, Monica M., Hillman, David W., Tenner, Kathleen S., Schroeder, Matthew J., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Harris, Lyndsay N., Gralow, Julie R., Dueck, Amylou C., Ketterling, Rhett P., Ingle, James N., Lingle, Wilma L., Kaufman, Peter A., Visscher, Daniel W., Jenkins, Robert B.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2010
विषय:
Original Reports
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954132/
https://ncbi.nlm.nih.gov/pubmed/20697084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.2154
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन